Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repolarization Study in Long QT Syndrome Type 2 Patients
2017-005082-47Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of bisoprolol in long QT syndrome (LQTS), sponsored by Helsinki University Hospital. Started Jan 2018; status: completed.
02
Drugs
bisoprolol
03
Conditions
long QT syndrome (LQTS)
Beyond the preview
Go deeper on 2017-005082-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005082-47.